EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudiePragmatische StudieOpen Access

Clostridioides difficile Near-Patient Testing Versus Centralized Testing: A Pragmatic Cluster Randomized Crossover Trial

Cody P Doolan, Babak Sahragard, Jenine Leal, Anuj Sharma, Joseph Kim, Eldon Spackman, Aidan Hollis, Dylan R Pillai

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad046 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Cody P Doolan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Canadian Institutes of Health Research, AMR One Health Consortium University of Calgary.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Management of suspected Clostridioides difficile infection (CDI) in the hospital setting typically results in patient isolation, laboratory testing, infection control, and presumptive treatment. We investigated whether implementation of rapid near-patient testing (NPT) reduced patient isolation time, hospital length of stay (LOS), antibiotic usage, and cost.

Methods

A 2-period pragmatic cluster randomized crossover trial was conducted. Thirty-nine wards were randomized into 2 study arms. The primary outcome measure was effect of NPT on patient isolation time using a mixed-effects generalized linear regression model. Secondary outcomes examined were hospital LOS and antibiotic therapy based on a negative binomial regression model. Natural experiment (NE), intention-to-treat (ITT), and per-protocol (PP) analyses were conducted.

Results

During the entire study period, a total of 656 patients received NPT for CDI and 1667 received standard-of-care testing. For the primary outcome, a significant decrease of patient isolation time with NPT was observed (NE, 9.4 hours [P < .01]; ITT, 2.3 hours [P < .05]; PP, 6.7 hours [P < .1]). A significant reduction in hospital LOS was observed with NPT for short stay (NE, 47.4% [P < .01]; ITT, 18.4% [P < .01]; PP, 34.2% [P < .01]). Each additional hour delay for a negative result increased metronidazole use (24 defined daily doses per 1000 patients; P < .05) and non-CDI-treating antibiotics by 70.13 mg (P < .01). NPT was found to save 25.48 US dollars per patient when including test cost to the laboratory and patient isolation in the hospital.

Conclusions

This pragmatic cluster randomized crossover trial demonstrated that implementation of CDI NPT can contribute to significant reductions in isolation time, hospital LOS, antibiotic usage, and healthcare cost. Clinical Trials Registration. NCT03857464.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileClostridium InfectionsHumansClostridioidesCross-Over StudiesAnti-Bacterial AgentsMetronidazole

Stichwörter der Autor:innen

Clostridium difficilecostdiagnosticsnear patient testingoutcomes

Substanzen

Anti-Bacterial AgentsMetronidazole

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, Alberta, Canada.
  • Department of Economics, Simon Fraser University, Burnaby, British Columbia, Canada.
  • Infection Prevention and Control, Alberta Health Services, Calgary, Alberta, Canada.
  • Department of Community Health Sciences, University of Calgary, Alberta, Canada.
  • Ephicacy Canada Inc., Toronto, Ontario, Canada.
  • Department of Medicine, University of Calgary, Calgary, Alberta, Canada.

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • AMR One Health Consortium University of Calgary

Zitieren

APA

Doolan, C. P., Sahragard, B., Leal, J., Sharma, A., Kim, J., Spackman, E., Hollis, A., & Pillai, D. R. (2023). Clostridioides difficile Near-Patient Testing Versus Centralized Testing: A Pragmatic Cluster Randomized Crossover Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad046

Vancouver

Doolan CP, Sahragard B, Leal J, Sharma A, Kim J, Spackman E, et al. Clostridioides difficile Near-Patient Testing Versus Centralized Testing: A Pragmatic Cluster Randomized Crossover Trial. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad046

BibTeX
@article{Doolan2023,
  author = {Doolan, Cody P and Sahragard, Babak and Leal, Jenine and Sharma, Anuj and Kim, Joseph and Spackman, Eldon and Hollis, Aidan and Pillai, Dylan R},
  title = {Clostridioides difficile Near-Patient Testing Versus Centralized Testing: A Pragmatic Cluster Randomized Crossover Trial},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad046}
}
Kostenlos starten →